These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21217783)

  • 1. The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
    Luo Y; Zhou H; Liu L; Shen T; Chen W; Xu B; Han X; Zhang F; Scott RS; Alexander JS; Alam A; Huang S
    Oncogene; 2011 May; 30(18):2098-107. PubMed ID: 21217783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.
    Luo Y; Chen W; Zhou H; Liu L; Shen T; Alexander JS; Zheng S; Lu Y; Huang S
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2083-91. PubMed ID: 21881029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.
    Luo Y; Liu L; Rogers D; Su W; Odaka Y; Zhou H; Chen W; Shen T; Alexander JS; Huang S
    Neoplasia; 2012 Mar; 14(3):228-37. PubMed ID: 22496622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
    Coso S; Zeng Y; Opeskin K; Williams ED
    PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.
    Shen T; Shang C; Zhou H; Luo Y; Barzegar M; Odaka Y; Wu Y; Huang S
    Genes Cancer; 2017 Mar; 8(3-4):505-516. PubMed ID: 28680535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
    Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
    Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
    Huang Z; Huang S
    Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
    Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
    PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
    Shen T; Huang S
    Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
    Sakima M; Hayashi H; Mamun AA; Sato M
    Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
    Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
    J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor activity of the fungicide ciclopirox.
    Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
    Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis.
    Goldman J; Rutkowski JM; Shields JD; Pasquier MC; Cui Y; Schmökel HG; Willey S; Hicklin DJ; Pytowski B; Swartz MA
    FASEB J; 2007 Apr; 21(4):1003-12. PubMed ID: 17210781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
    Iwami D; Brinkman CC; Bromberg JS
    Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1.
    Zhang X; Groopman JE; Wang JF
    J Cell Physiol; 2005 Jan; 202(1):205-14. PubMed ID: 15389531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.